These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 10827178
1. Feedback control of cyclooxygenase-2 expression through PPARgamma. Inoue H, Tanabe T, Umesono K. J Biol Chem; 2000 Sep 08; 275(36):28028-32. PubMed ID: 10827178 [Abstract] [Full Text] [Related]
2. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK. Proc Natl Acad Sci U S A; 2000 Apr 25; 97(9):4844-9. PubMed ID: 10781090 [Abstract] [Full Text] [Related]
7. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Grau R, Iñiguez MA, Fresno M. Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320 [Abstract] [Full Text] [Related]
10. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. Badawi AF, Badr MZ. Int J Cancer; 2003 Jan 01; 103(1):84-90. PubMed ID: 12455057 [Abstract] [Full Text] [Related]
11. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism. Kalajdzic T, Faour WH, He QW, Fahmi H, Martel-Pelletier J, Pelletier JP, Di Battista JA. Arthritis Rheum; 2002 Feb 01; 46(2):494-506. PubMed ID: 11840453 [Abstract] [Full Text] [Related]
12. Dexmedetomidine inhibits LPS-induced inflammatory responses through peroxisome proliferator-activated receptor gamma (PPARγ) activation following binding to α2 adrenoceptors. Fujimoto M, Higuchi H, Honda-Wakasugi Y, Miyake S, Nishioka Y, Yabuki-Kawase A, Maeda S, Miyawaki T. Eur J Pharmacol; 2021 Feb 05; 892():173733. PubMed ID: 33220278 [Abstract] [Full Text] [Related]
13. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. Kim HY, Kim HS. Immunol Cell Biol; 2007 Jan 05; 85(1):60-7. PubMed ID: 17130903 [Abstract] [Full Text] [Related]
14. Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways. Paik JH, Ju JH, Lee JY, Boudreau MD, Hwang DH. J Biol Chem; 2000 Sep 08; 275(36):28173-9. PubMed ID: 10866999 [Abstract] [Full Text] [Related]
16. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. Hinz B, Brune K, Pahl A. Biochem Biophys Res Commun; 2003 Mar 07; 302(2):415-20. PubMed ID: 12604364 [Abstract] [Full Text] [Related]
18. 15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma. Zhang J, Fu M, Zhao L, Chen YE. Biochem Biophys Res Commun; 2002 Oct 18; 298(1):128-32. PubMed ID: 12379230 [Abstract] [Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation. Na HK, Surh YJ. Biochem Pharmacol; 2003 Oct 15; 66(8):1381-91. PubMed ID: 14555212 [Abstract] [Full Text] [Related]
20. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway. Boyault S, Bianchi A, Moulin D, Morin S, Francois M, Netter P, Terlain B, Bordji K. FEBS Lett; 2004 Aug 13; 572(1-3):33-40. PubMed ID: 15304320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]